Jeffrey mICHAEL Kubiak, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Borrelia | 1 | 2024 | 66 | 0.900 |
Why?
|
| Meningoencephalitis | 1 | 2024 | 82 | 0.870 |
Why?
|
| Mycobacterium | 1 | 2023 | 253 | 0.780 |
Why?
|
| Norovirus | 1 | 2021 | 36 | 0.720 |
Why?
|
| Fungi | 1 | 2023 | 348 | 0.710 |
Why?
|
| Fluoroquinolones | 1 | 2022 | 307 | 0.680 |
Why?
|
| Serine Endopeptidases | 3 | 2018 | 1024 | 0.600 |
Why?
|
| Rec A Recombinases | 1 | 2017 | 50 | 0.570 |
Why?
|
| Immunoglobulin M | 2 | 2022 | 1528 | 0.540 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5753 | 0.420 |
Why?
|
| DNA Damage | 2 | 2018 | 2457 | 0.360 |
Why?
|
| Bacterial Proteins | 3 | 2018 | 3837 | 0.340 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 4528 | 0.330 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1748 | 0.330 |
Why?
|
| Escherichia coli | 2 | 2018 | 4214 | 0.300 |
Why?
|
| Borrelia Infections | 1 | 2024 | 18 | 0.230 |
Why?
|
| Sarcina | 1 | 2023 | 10 | 0.220 |
Why?
|
| Minnesota | 1 | 2024 | 336 | 0.220 |
Why?
|
| Enterobacteriaceae | 1 | 2022 | 161 | 0.180 |
Why?
|
| beta-Lactamases | 1 | 2022 | 308 | 0.170 |
Why?
|
| Stomach | 1 | 2023 | 699 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 125 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 7478 | 0.160 |
Why?
|
| Capsid Proteins | 1 | 2020 | 467 | 0.140 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 834 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 6069 | 0.110 |
Why?
|
| Diarrhea | 1 | 2021 | 1316 | 0.110 |
Why?
|
| Acute Disease | 1 | 2024 | 7232 | 0.110 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3211 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2020 | 1159 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2018 | 2968 | 0.070 |
Why?
|
| Bacteria | 1 | 2018 | 2209 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2023 | 81514 | 0.060 |
Why?
|
| Humans | 9 | 2024 | 765968 | 0.050 |
Why?
|
| Clostridium | 1 | 2023 | 100 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
| Pregnancy | 2 | 2022 | 30260 | 0.050 |
Why?
|
| Chemokine CXCL10 | 1 | 2022 | 310 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26346 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 297 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7875 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2022 | 251 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 10808 | 0.040 |
Why?
|
| Convalescence | 1 | 2020 | 107 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2022 | 700 | 0.040 |
Why?
|
| Virion | 1 | 2020 | 430 | 0.040 |
Why?
|
| Female | 6 | 2023 | 396112 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2022 | 575 | 0.030 |
Why?
|
| Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
| Immunoassay | 1 | 2020 | 741 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 54802 | 0.030 |
Why?
|
| Microvessels | 1 | 2020 | 591 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 223009 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2018 | 1077 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 2018 | 746 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2020 | 2864 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2023 | 59489 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2018 | 1141 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 938 | 0.020 |
Why?
|
| Kinetics | 1 | 2018 | 6274 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2018 | 1064 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3449 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3584 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7421 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5786 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14751 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2018 | 3458 | 0.010 |
Why?
|
| Lung | 1 | 2020 | 10033 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 171117 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41649 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40065 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 223044 | 0.010 |
Why?
|
| Male | 2 | 2020 | 363698 | 0.010 |
Why?
|